Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

Patent 12129275 was granted and assigned to SAGE Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121292750

Patent Inventor Names

Ravindra B. Upasani0

Benny C. Askew0

Boyd L. Harrison0

Albert Jean Robichaud0

Jean-Cosme Dodart0

Francesco G. Salituro0

Date of Patent

October 29, 2024

Patent Application Number

177073030

Date Filed

March 29, 2022

Patent Citations

‌

US Patent 8673843 NMDA receptors modulators and uses thereof

‌

US Patent 8829213 Liver X receptor agonists

‌

US Patent 10201550 Oxysterols and methods of use thereof

‌

US Patent 10227375 Neuroactive steroids and methods of use thereof

‌

US Patent 10259840 Oxysterols and methods of use thereof

‌

US Patent 10696712 Oxysterols and methods of use thereof

‌

US Patent 10723758 Oxysterols and methods of use thereof

‌

US Patent 10752653 Oxysterols and methods of use thereof

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API